Simcere Pharmaceutical Group Ltd
HKEX:2096

Watchlist Manager
Simcere Pharmaceutical Group Ltd Logo
Simcere Pharmaceutical Group Ltd
HKEX:2096
Watchlist
Price: 6.78 HKD 2.11%
Market Cap: 17.1B HKD
Have any thoughts about
Simcere Pharmaceutical Group Ltd?
Write Note

Simcere Pharmaceutical Group Ltd
Investor Relations

Simcere Pharmaceutical Group Ltd., established in China, navigates the complexities of the pharmaceutical industry with a focus on innovation and accessibility. Emerging as a dynamic player, Simcere embraces a strategy that marries research-driven innovation with pragmatic commercial practices. The company operates a diversified portfolio, prominently featuring pharmaceuticals dedicated to oncology, cardiovascular diseases, and the central nervous system. By maintaining a robust pipeline of new drug candidates while leveraging its existing catalog, Simcere adeptly navigates the challenges of the pharma landscape. Their dedication to research and development is evident, with substantial investment channeled towards creating proprietary medicines that aim to address unmet medical needs and improve patient outcomes.

The path to profitability for Simcere hinges on its dual strategy of developing novel therapeutics and forming strategic partnerships. Simcere not only invests heavily in its proprietary R&D but also engages in collaborations with global pharmaceutical enterprises, thus expanding its reach and influence in the global market. The company adeptly manages a sophisticated supply chain to ensure its products are both widely distributed and affordable, adhering to high standards of regulatory compliance in various metropolises. This operational efficiency, coupled with the strategic alliances, allows Simcere to capture significant market share, driving top-line growth and reinforcing its reputation as an innovative leader in the pharmaceutical industry.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Jinsheng Ren
Co-Founder, Chairman & CEO
No Bio Available
Mr. Yushan Wan
CFO, Joint Company Secretary & Executive Director
No Bio Available
Mr. Renhong Tang Ph.D.
Executive Director
No Bio Available
Ms. Xi Wang
VP & Executive Director
No Bio Available
Mr. Gaobo Zhou
Chief Investment Officer
No Bio Available
Mr. Quanfu Feng
Vice President of Marketing
No Bio Available
Dr. Tamas Oravecz Ph.D.
Senior VP & Chief Scientific Officer of Simcere Zaiming
No Bio Available
Dr. Aik Han Goh
Senior VP & Chief Medical Officer
No Bio Available
Mr. Wang John
Senior Vice President
No Bio Available
Dr. Yongyu Wang
Senior VP & Chief Medical Officer of Simcere Zaiming
No Bio Available

Contacts

Address
JIANGSU
Nanjing
No. 699-18, Xuanwu Avenue, Xuanwu District
Contacts